References
- Kim LK, Swaminathan RV, Looser P, Minutello RM, Wong SC, Bergman G, et
al. Hospital volume outcomes after septal myectomy and alcohol septal
ablation for treatment of obstructive hypertrophic cardiomyopathy: US
Nationwide Inpatient Database, 2003-2011. JAMA Cardiol 2016; 1:
324-32.
- Nguyen A, Schaff HV, Hang D, Nishimura RA, Geske JB, Dearani JA, et
al. Surgical myectomy versus alcohol septal ablation for obstructive
hypertrophic cardiomyopathy: A propensity score-matched cohort. J
Thorac Cardiovasc Surg 2019; 157: 306-15. e3.
- Ommen SR, Maron BJ, Olivotto I, Maron MS, Cecchi F, Betocchi S, et al.
Long-term effects of surgical septal myectomy on survival in patients
with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 2005;
46: 470-6.
- Woo A, Williams WG, Choi R, Wigle ED, Rozenblyum E, Fedwick K, et al.
Clinical and echocardiographic determinants of long-term survival
after surgical myectomy in obstructive hypertrophic cardiomyopathy.
Circulation 2005; 111: 2033-41.
- Ball W, Ivanov J, Rakowski H, Wigle Ed, Linghorne M, Ralph-Edwards A,
et al. Long-term survival in patients with resting obstructive
hypertrophic cardiomyopathy: comparison of conservative versus
invasive treatment. J Am Coll Cardiol 2011; 58: 2313-21.
- Desai MY, Bhonsale A, Smedira NG, Naji P, Thamilarasan M, Lytle BW, et
al. Predictors of long-term outcomes in symptomatic hypertrophic
obstructive cardiomyopathy patients undergoing surgical relief of left
ventricular outflow tract obstruction. Circulation 2013; 128: 209-1.
- Dearani JA, Ommen SR, Gersh BJ, Schaff HV, Danielson GK. Surgery
insight: Septal myectomy for obstructive hypertrophic
cardiomyopathy–the Mayo Clinic experience. Nat Clin Pract
Cardiovasc Med 2007; 4: 503-12.
- Ferrazzi P, Spirito P, Iacovoni A, Calabrese A, igliorati K, Simon C,
et al. Transaortic chordal cutting: mitral valve repair for
obstructive hypertrophic cardiomyopathy with mild septal hypertrophy.
J Am Coll Cardiol 2015; 66: 1687-99.
- Iacovoni A, Spirito P, Simon C, Iascone M, Di Dedda G, De Filippo P,
et al. A contemporary European experience with surgical septal
myectomy in hypertrophic cardiomyopathy. Eur Heart J 2012; 33: 2080-7.
- Smedira NG, Lytle BW, Lever HM, Rajeswaran J, Krishnaswamy G, Kaple
RK, et al. Current effectiveness and risks of isolated septal myectomy
for hypertrophic obstructive cardiomyopathy. Ann Thorac Surg 2008; 85:
127-33.
- Ommen SR, Nishimura RA. Hypertrophic cardiomyopathy – one case per
year? A clarion call to do what is right. JAMA Cardiol 2016; 1: 333-4.
- Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron
P, et al. 2014 ESC Guidelines on Diagnosis and Management of
Hypertrophic Cardiomyopathy: the Task Force for the Diagnosis and
Management of Hypertrophic Cardiomyopathy of the European Society of
Cardiology (ESC). Eur Heart J 2014; 35: 2733-79.
- Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, et al.
2011 ACCF/AHA guideline for the diagnosis and treatment of
hypertrophic cardiomyopathy: executive summary: a report of the
American College of Cardiology Foundation/American Heart Association
Task Force on Practice Guidelines. Circulation 2011; 124: 2761-96.
- Cho YH, Quintana E, Schaff HV, Nishimura RA, Dearani JA, Abel MD, et
al. Residual and recurrent gradients after septal myectomy for
hypertrophic cardiomyopathy-mechanisms of obstruction and outcomes of
reoperation. J Thorac Cardiovasc Surg 2014; 148: 909-916.
- Maron BJ, Yacoub M, Dearani JA. Controversies in cardiovascular
medicine. Benefits of surgery in obstructive hypertrophic
cardiomyopathy: bring septal myectomy back for European patients. Eur
Heart J 2011; 32: 1055-8.
- Rosca M, Calin A, Beladan CC, Enache R, Mateescu AD, Gurzun MM, et al.
Right ventricular remodeling, its correlates, and its clinical impact
in hypertrophic cardiomyopathy. J Am Soc Echocardiogr 2015; 28:
1329-38.
- Spirito P, Binaco I, Poggio D, Zyrianov A, Grillo M, Pezzoli L, et al.
Role of preoperative cardiovascular magnetic resonance in planning
ventricular septum myectomy in patients with obstructive hypertrophic
cardiomyopathy. Am J Cardiol 2019; 123: 1517-26.
- Yang DH, Kang JW, Kim N, Song JK, Lee JW, Lim TH. Myocardial
3‑dimensional printing for septal myectomy guidance in a patient with
obstructive hypertrophic cardiomyopathy. Circulation 2015; 132: 300-1.
- Dorobantu L, Ticulescu R, Greavu M, Dermengiu A, Alexandrescu M,
Trofin M. Current management and surgical advances in patients with
hypertrophic obstructive cardiomyopathy. Kardiol Pol 2019; 77:
829-836.
- Rodriguez F, Langer F, Harrington KB, Tibayan FA, Zasio MK, Cheng A,
et al. Importance of mitral valve second-order chordae for left
ventricular geometry, wall thickening mechanics, and global systolic
function. Circulation 2004; 110: II115-22.
- Wang S, Cui H, Yu Q, Chen H, Zhu C, Wang J, et al. Excision of
anomalous muscle bundles as an important addition to extended septal
myectomy for treatment of left ventricular outflow tract obstruction.
J Thorcac Cardiovasc Surg 2016; 152: 461-468.
- Patel P, Dhillon A, Popovic ZB, Smedira NG, Rizzo J, Thamilarasan M,
et al. Left ventricular outflow tract obstruction in hypertrophic
cardiomyopathy patients without severe septal hypertrophy:
implications of mitral valve and papillary muscle abnormalities
assessed using cardiac magnetic resonance and echocardiography.Circ Cardiovasc Imaging 2015; 8: e003132.
- Hodges K, Rivas CG, Aguilera J, Borden R, Alashi A, Blackstone EH, et
al. Surgical management of left ventricular outflow tract obstruction
in a specialized hypertrophic obstructive cardiomyopathy center. J
Thorac Cardiovasc Surg 2019; 157: 2289-2299.